Article: Wright Medical Group Gets FDA OK to Market Conserve Plus Total Hip Resurfacing System.

Wright Medical Group, Inc., a global orthopaedic medical device company, announced that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original Conserve Plus Total Hip Resurfacing System.

Now available in the United States, this total surface arthroplasty system provides surgeons and their patients a bone-conserving alternative to traditional total hip replacement, the Company noted in a release.

Wright said that the approval permits Wright to market Conserve Plus in the original femoral and acetabular component configuration specified in its PreMarket Approval (PMA) application and enables the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!